Correction: Translational Modeling Predicts Efficacious Therapeutic Dosing Range of Teclistamab for Multiple Myeloma
Target Oncol
.
2022 Sep;17(5):609.
doi: 10.1007/s11523-022-00904-y.
Authors
Suzette Girgis
1
,
Shun Xin Wang Lin
2
,
Kodandaram Pillarisetti
2
,
Arnob Banerjee
2
,
Tara Stephenson
2
,
Xuewen Ma
2
,
Shoba Shetty
2
,
Tong-Yuan Yang
2
,
Brandi W Hilder
2
,
Qun Jiao
2
,
Brett Hanna
2
,
Homer C Adams 3rd
2
,
Yu-Nien Sun
2
,
Amarnath Sharma
3
,
Jennifer Smit
2
,
Jeffrey R Infante
4
,
Jenna D Goldberg
4
,
Yusri Elsayed
2
Affiliations
1
Janssen Research & Development, 920 Route 202, Raritan, NJ, 08869, USA. SGirgis@its.jnj.com.
2
Janssen Research & Development, Spring House, PA, USA.
3
Janssen Research & Development, Tokyo, Japan.
4
Janssen Research & Development, 920 Route 202, Raritan, NJ, 08869, USA.
PMID:
35913648
PMCID:
PMC9512742
DOI:
10.1007/s11523-022-00904-y
No abstract available
Publication types
Published Erratum